HEALTHEURACTIV
Commission celebrates “milestone” in the assessment of innovative medicines
The Commission has celebrated a milestone in the assessment of innovative medicines by issuing the first outcome of the new Health Technology Assessment (HTA) framework.
Related Signal
Adjacent reporting
- Waters CEO highlights China as key innovation source in the biopharma market
- China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
- AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
- Innovation in medicine is having a breakthrough moment
- NHS approves first new ovarian cancer treatment for 20 years
- STAT+: Eli Lilly tops prominent rankings on pharma R&D performance